Document is current
Any future updates will be listed below
-
Authors
Inayatullah, Mohammed
Mahesh, Arun https://orcid.org/0000-0002-4980-8014
Turnbull, Arran K
Dixon, J Michael https://orcid.org/0000-0002-7583-331X
Natrajan, Rachael https://orcid.org/0000-0002-9987-2946
Tiwari, Vijay K https://orcid.org/0000-0003-0292-6635
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (TI 799/1-3)
UKRI | Innovate UK (iCURE)
- License Information
-
More Information
Article History
Received: 11 November 2023
Revised: 7 February 2024
Accepted: 14 February 2024
First Online: 13 March 2024
Disclosure and competing interests statement
: The identified 20-gene biomarker panel has been filed for a patent for the prediction of chemotherapy response in triple-negative breast cancer (TNBC) with accession WO 2023/099890 A1; PCT/GB2022/053035.
